Sorrell v. IMS Health Inc.: Battle may be won, but war is not over


A recent article from The RPM Report, posted on the Coalition for Healthcare Communication's website, provides an excellent summary of the Supreme Court’s decision in Sorrell v. IMS Health Inc. and discusses the decision’s implications for the pharmaceutical industry. Coalition Executive Director John Kamp is quoted in this insightful article, which states that "the Supreme Court opinion may well mean the end of direct threats to the use of physician prescribing data, but it doesn’t mean that states -- and perhaps, a few interested members of Congress -- won’t find other ways to achieve the same goals." Read more.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations